The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arch Venture Fund Xii, L.p. since 2024.
This trader's CIK number is 1906837.
At the time of last reporting, Arch Venture Fund Xii, L.p. was the 10% Owner of Prime Medicine, Inc.. (stock ticker symbol PRME).
Also see all insider trading activities at Prime Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PRME | 3,030,300 | $9,999,990 | 0 | $0 | 0 | $0 |
| 2024 | PRME | 3,200,000 | $20,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-01 | PRME | Buy | 3,030,300 | 3.30 | 9,999,990 |
| 2024-02-15 | PRME | Buy | 3,200,000 | 6.25 | 20,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arch Venture Fund Xii, L.p. (10% Owner of Prime Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.